These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15208496

  • 1. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma.
    Boschi A, Uccelli L, Duatti A, Colamussi P, Cittanti C, Filice A, Rose AH, Martindale AA, Claringbold PG, Kearney D, Galeotti R, Turner JH, Giganti M.
    Nucl Med Commun; 2004 Jul; 25(7):691-9. PubMed ID: 15208496
    [Abstract] [Full Text] [Related]

  • 2. 188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma.
    Garin E, Denizot B, Noiret N, Lepareur N, Roux J, Moreau M, Herry JY, Bourguet P, Benoit JP, Lejeune JJ.
    Nucl Med Commun; 2004 Oct; 25(10):1007-13. PubMed ID: 15381868
    [Abstract] [Full Text] [Related]

  • 3. Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs.
    Garin E, Noiret N, Malbert C, Lepareur N, Roucoux A, Caulet-Maugendre S, Moisan A, Lecloirec J, Herry JY, Bourguet P.
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):542-6. PubMed ID: 14691613
    [Abstract] [Full Text] [Related]

  • 4. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection.
    Luo TY, Hsieh BT, Wang SJ, Lin WY, Lee TW, Shen LH, Su MJ.
    Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287
    [Abstract] [Full Text] [Related]

  • 5. Improved freeze-dried kit for the preparation of 188ReN-DEDC/lipiodol for the therapy of unresectable hepatocellular carcinoma.
    Mallia MB, Chirayil V, Dash A.
    Appl Radiat Isot; 2018 Jul; 137():147-153. PubMed ID: 29625347
    [Abstract] [Full Text] [Related]

  • 6. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial.
    Lambert B, Bacher K, Defreyne L, Gemmel F, Van Vlierberghe H, Jeong JM, Dierckx RA, Van de Wiele C, Thierens H, De Vos F.
    J Nucl Med; 2005 Jan; 46(1):60-6. PubMed ID: 15632035
    [Abstract] [Full Text] [Related]

  • 7. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma.
    Sundram F, Chau TC, Onkhuudai P, Bernal P, Padhy AK.
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
    Tang IC, Luo TY, Liu SW, Chan SH, Kung HC, Peng CL, Lin WY, Chang Y, Lin WJ.
    Nucl Med Biol; 2011 Oct; 38(7):1043-52. PubMed ID: 21831647
    [Abstract] [Full Text] [Related]

  • 9. (188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.
    Lambert B, Bacher K, Defreyne L, Van Vlierberghe H, Jeong JM, Wang RF, van Meerbeeck J, Smeets P, Troisi R, Thierens H, De Vos F, Van de Wiele C.
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):344-52. PubMed ID: 16333675
    [Abstract] [Full Text] [Related]

  • 10. 188 Re-N-DEDC Lipiodol for Treatment of Hepatocellular Carcinoma (HCC)-A Clinical and Prospective Study to Assess In-Vivo Distribution in Patients and Clinical Feasibility of Therapy.
    Kumar N, Gupta P, Shamim SA, Chirayil V, Subramanian S, Mallia MB, Bal C.
    World J Nucl Med; 2023 Jun; 22(2):114-123. PubMed ID: 37223628
    [Abstract] [Full Text] [Related]

  • 11. Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization.
    Delaunay K, Edeline J, Rolland Y, Lepareur N, Laffont S, Palard X, Bouvry C, Le Sourd S, Pracht M, Ardisson V, Noiret N, Bellissant É, Garin E.
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1506-1517. PubMed ID: 30715571
    [Abstract] [Full Text] [Related]

  • 12. Preparation and imaging of rhenium-188 labeled human serum albumin microsphere in orthotopic hepatoma rats.
    Ni HC, Yu CY, Chen SJ, Chen LC, Lin CH, Lee WC, Chuang CH, Ho CL, Chang CH, Lee TW.
    Appl Radiat Isot; 2015 May; 99():117-21. PubMed ID: 25748057
    [Abstract] [Full Text] [Related]

  • 13. Empirical 188Re-HDD/lipiodol intra-arterial therapy based on tumor volume, in patients with solitary inoperable hepatocellular carcinoma.
    Shinto AS, Karuppusamy KK, Kurup RER, Pandiyan A, Jayaraj AV.
    Nucl Med Commun; 2021 Jan; 42(1):43-50. PubMed ID: 32956248
    [Abstract] [Full Text] [Related]

  • 14. Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol.
    Lee YS, Jeong JM, Kim YJ, Chang YS, Lee HJ, Son M, Lee JW, Yoon HS, Kang WJ, Lee DS, Chung JK, Lee MC, Suh YG.
    Appl Radiat Isot; 2007 Jan; 65(1):64-9. PubMed ID: 17010628
    [Abstract] [Full Text] [Related]

  • 15. Radiolabelling of Lipiodol with generator-produced 188Re for hepatic tumor therapy.
    Wang SJ, Lin WY, Chen MN, Hsieh BT, Shen LH, Tsai ZT, Ting G, Knapp FF.
    Appl Radiat Isot; 1996 Mar; 47(3):267-71. PubMed ID: 8935963
    [Abstract] [Full Text] [Related]

  • 16. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer.
    Das T, Chakraborty S, Sarma HD, Venkatesh M, Banerjee S.
    Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794
    [Abstract] [Full Text] [Related]

  • 17. Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma.
    Shih YH, Lin XZ, Yeh CH, Peng CL, Shieh MJ, Lin WJ, Luo TY.
    Int J Nanomedicine; 2014 May; 9():4191-201. PubMed ID: 25214783
    [Abstract] [Full Text] [Related]

  • 18. Advantage of 188Re-radiopharmaceuticals in hepatocellular cancer and liver metastases.
    Liepe K, Kotzerke J, Lambert B.
    J Nucl Med; 2005 Aug; 46(8):1407-8; author reply 1407-8. PubMed ID: 16085601
    [No Abstract] [Full Text] [Related]

  • 19. Development of 99mTc labelled Lipiodol: biodistribution following injection into the hepatic artery of the healthy pig.
    Garin E, Noiret N, Malbert CH, Lepareur N, Roucoux A, Dazord L, Caulet-Maugendre S, Turlin B, Moisan A, Lecloirec J, Herry JY, Boucher E, Raoul JL, Bourguet P.
    Nucl Med Commun; 2004 Mar; 25(3):291-7. PubMed ID: 15094449
    [Abstract] [Full Text] [Related]

  • 20. Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma.
    Uccelli L, Pasquali M, Boschi A, Giganti M, Duatti A.
    Nucl Med Biol; 2011 Feb; 38(2):207-13. PubMed ID: 21315276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.